Status:
COMPLETED
Randomized Controlled Trial of Standard Versus Systemic Decolonization Therapy for the Eradication of Methicillin-resistant Staphylococcus Aureus (MRSA) Colonization
Lead Sponsor:
Horizon Health Network
Conditions:
Methicillin-resistant Staphylococcus Aureus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
MRSA decolonization may reduce the risk of subsequent MRSA infection and further transmission. A recent randomized controlled trial demonstrated that systemic decolonization may be safe and effective ...
Eligibility Criteria
Inclusion
- Any patient colonized with MRSA
Exclusion
- Currently on treatment with antibiotics
- Pregnant or breastfeeding women
- Active infection
- Hepatic cirrhosis or abnormal INR due to liver disease
- Decolonization in the previous two (2) months
- MRSA bacteria resistant to one or more of the study medications
- AST and ALT levels more than five times the upper limit of normal.
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01438515
Start Date
August 1 2008
End Date
December 31 2019
Last Update
February 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Saint John Regional Hospital
Saint John, New Brunswick, Canada, E2L4L2